Picture of Trilogy International Partners logo

TRL.H — Trilogy International Partners News Story

0.000.00%
ca flag iconLast trade - 00:00
TelecomsSpeculativeMicro CapContrarian

Brief: Endo acquires rights to Natesto testosterone nasal gel

Nov 24 (Reuters) - Endo International PLC  ENDP.O : 
 * Acquires rights to Natesto(TM) testosterone nasal gel 
 * Says under the terms of the agreement Trimel will receive an upfront payment 
   of $25 million 
 * Trimel will be responsible for the manufacture and supply of Natesto(TM) and 
   Endo will pay a tiered supply price for the product 
 * Under terms of the agreement, Endo receives sole and exclusive commercial 
   rights to the Natesto(TM) product in the US and Mexico 
 * Says could receive additional payments upon the achievement of certain 
   regulatory and sales milestones 
 
* Source text for Eikon  ID:nPn1yQpx3  
 
* Further company coverage  ENDP.O  ((Bangalore Newsroom; +1 646 223 8780))

Recent news on Trilogy International Partners

See all news